Send us a text A new flu variant is surging, the CDC just changed a long-standing recommendation for newborns, and a sweeping review questions the benefits many expect from medical cannabis. We unpack what’s real, what’s uncertain, and what to do next—without the hype. We start with H3N2 subclade K, now dominant across the U.S. and Europe. After a slower start, holiday travel set the stage for a later flu peak, with children and older adults likely feeling the brunt. While vaccine match data...